American Diabetes Association
Online-Only_Supplemental_Material-revised_01.14.2022.pdf (376.66 kB)

Lifetime Cardiovascular Disease Risk by Coronary Artery Calcium Score in Individuals With and Without Diabetes: An Analysis From the Multi-Ethnic Study of Atherosclerosis

Download (376.66 kB)
posted on 2022-02-15, 22:37 authored by Bart S. Ferket, M.G. Myriam Hunink, Umesh Masharani, Wendy Max, Joseph Yeboah, Gregory L. Burke, Kirsten E. Fleischmann

To assess lifetime cardiovascular disease (CVD) risks by coronary artery calcium (CAC) scores in individuals with diabetes from the Multi-Ethnic Study of Atherosclerosis (MESA) and compare risks with those without diabetes.

Research Design and Methods

We developed a microsimulation model with ‘Well’, ‘Diabetes’, ‘Post CVD’, and ‘Death’ health states using multivariable time-dependent Cox regression with age as time scale. We initially used 10-year follow-up data of 6769 MESA participants including coronary heart disease (N=272), heart failure (N=201), stroke (N=186), and competing death (N=272), and assessed predictive validity at 15 years. We externally validated the model in matched National Health and Nutrition Examination Survey (NHANES) participants. Subsequently we predicted CVD risk until age 100 by diabetes, 10-year Pooled Cohort Equations risk, and CAC score categories (0, 1-100, 100+).


The model showed good calibration and discriminative performance at 15 years with discrimination indices 0.71-0.78 across outcomes. In the NHANES cohort, predicted 15-year mortality risk corresponded well with Kaplan-Meier risks, especially for those with diabetes: 29.6% (95% CI 24.9-34.8) vs 32.4% (95% CI 27.2-37.2), respectively. Diabetes increased lifetime CVD risk similar to shifting one CAC category upwards (from 0 to 1-100 or from 1-100 to 100+). Patients with diabetes and zero CAC scores had lifetime CVD risks that overlapped with those without diabetes who are at low 10-year Pooled Cohort Equations risk <7.5%.


Patients with diabetes carry a spectrum of CVD risk. CAC scoring may improve decisions for preventive interventions for patients with diabetes by better delineating lifetime CVD risks.


Sources of Funding: The Multi-Ethnic Study of Atherosclerosis (MESA) was supported by contracts HHSN268201500003I, N01-HC-95159, N01-HC-95160, N01-HC-95161, N01-HC-95162, N01-HC-95163, N01-HC-95164, N01-HC-95165, N01-HC-95166, N01-HC-95167, N01-HC-95168 and N01-HC-95169 from the National Heart, Lung, and Blood Institute, and by grants UL1-TR-000040, UL1-TR-001079, and UL1-TR-001420 from the National Center for Advancing Translational Sciences (NCATS). Drs. Ferket, Hunink, Max, Masharani, and Fleischmann were supported by American Diabetes Association grant #1-18-ICTS-041. Role of the Funder/Sponsor: The American Diabetes Association had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or the decision to submit the manuscript for publication.